SUMMARY
Focal malformations of cortical development (FMCDs), including focal cortical dysplasia (FCD) and hemimegalencephaly (HME), are major etiologies of pediatric intractable epilepsies exhibiting cortical dyslamination. Brain somatic mutations in MTOR have recently been identified as a major genetic cause of FMCDs. However, the molecular mechanism by which these mutations lead to cortical dyslamination remains poorly understood. Here, using patient tissue, genome-edited cells, and mouse models with brain somatic mutations in MTOR, we discovered that disruption of neuronal ciliogenesis by the mutations underlies cortical dyslamination in FMCDs. We found that abnormal accumulation of OFD1 at centriolar satellites due to perturbed autophagy was responsible for the defective neuronal ciliogenesis. Additionally, we found that disrupted neuronal ciliogenesis accounted for cortical dyslamination in FMCDs by compromising Wnt signals essential for neuronal polarization. Altogether, this study describes a molecular mechanism by which brain somatic mutations in MTOR contribute to the pathogenesis of cortical dyslamination in FMCDs.
INTRODUCTION
Focal malformations of cortical development (FMCDs), including hemimegalencephaly (HME) and focal cortical dysplasia (FCD), are a heterogeneous group of cortical abnormalities that are highly associated with medically intractable epilepsy, intellectual disability, developmental delay, and autism-spectrum disorders (Foldvary-Schaefer et al., 2004; Lim and Crino, 2013; Wegiel et al., 2010) . Despite a broad spectrum of cortical abnormalities in FMCDs, defective neuronal migration and cortical dyslamination are considered common pathological hallmarks (FoldvarySchaefer et al., 2004) . The genetic etiologies of FCD and HME, however, have only recently begun to be uncovered. We and other study groups have found that brain somatic mutations in MTOR (mechanistic target of rapamycin) cause both FCD and HME, suggesting that a common molecular mechanism related to the mTOR pathway underlies cortical abnormalities (Crino, 2016; D'Gama et al., 2015 D'Gama et al., , 2017 Lee et al., 2012a; Lim et al., 2015; Mirzaa et al., 2016; Møller et al., 2016; Nakashima et al., 2015) . MTOR is a highly conserved serine/threonine kinase and a well-studied central regulator of the mTOR pathway, the activation of which inhibits autophagy process (Laplante and Sabatini, 2012) . Nonetheless, the molecular mechanisms by which brain somatic mutations in MTOR lead to cortical dyslamination and malpositioned neurons in FMCDs remain unclear.
A precisely regulated process, neuronal migration in the cerebral cortex is important to the formation of neuronal circuitry (Ayala et al., 2007; Evsyukova et al., 2013) . Proper, coordinated intracellular responses to extracellular guidance cues are essential for the migration of neurons from their zone of origin to their destination in the cortex, and neuronal misplacement resulting from defects therein leads to abnormal cortical function (Ayala et al., 2007; Evsyukova et al., 2013; Gleeson and Walsh, 2000) . Among organelles in the cell that sense extracellular cues, primary cilia, which are non-motile, microtubule-based organelles, are known to integrate many important signaling pathways, such as Wnt, Sonic hedgehog (Shh), and platelet-derived growth factor (PDGF) (Bangs and Anderson, 2016; Corbit et al., 2005; Hilgendorf et al., 2016; May-Simera and Kelley, 2012) , thereby regulating vertebrate development and homeostasis (Goetz and Anderson, 2010; Guemez-Gamboa et al., 2014) . In the brain, neuronal cilia are implicated in cortical patterning, neurogenesis, neuronal maturation, and cerebellar development (Lee and Gleeson, 2010) . In a recent report, primary cilia were found to play a guiding role in the migration and placement of developing interneurons mediating Shh signaling (Baudoin et al., 2012; Higginbotham et al., 2012 Higginbotham et al., , 2013 . Neuronal ciliamediated signaling has been shown to be essential for the initial formation of radial progenitor scaffolds and, when disrupted, to cause aberrant neuronal placement (Higginbotham et al., 2013) . Also, genes linked to ciliopathies, a group of syndromic disorders caused by ciliary dysfunction, affect the cortical development including neural progenitor development, neuronal radial migration, neuronal differentiation, and early neuronal connectivity (Guo et al., 2015) . However, the role of primary cilia in the pathogenesis of FMCDs, especially defects of radially migrating neurons, caused by brain somatic mutations in MTOR is unclear.
In the present study, we observed severely defective neuronal ciliogenesis not only in brain tissues from FMCD patients, but also in a CRISPR-Cas9 genome-edited cell line and mouse models with brain somatic mutation in MTOR. We then discovered that brain somatic mutations in MTOR elicited severely defective neuronal ciliogenesis by disturbing the autophagy process. Abnormal accumulation of OFD1 protein at centriolar satellites due to disturbed autophagy resulted in defective neuronal ciliogenesis. We further noted that defective neuronal ciliogenesis caused cortical dyslamination in FMCDs by disturbing Wnt signaling. Taken together, our results highlight a molecular mechanism by which brain somatic mutations in MTOR contribute to the pathogenesis of cortical dyslamination in FMCDs.
RESULTS

Brain Somatic Mutations in MTOR Result in Defective
Neuronal Ciliogenesis HME and FCD patients exhibit cortical dyslamination with dysmorphic neurons and catastrophic epilepsy that is medically intractable, and surgical resection of the affected brain is necessary to alleviate epileptic episodes ( Figure 1A ). To examine whether neuronal cilia are defective in FMCD patients with brain somatic mutations in MTOR, we immunostained for the ciliary marker Arl13b in surgically resected brain tissues from HME and FCD patients with brain somatic mutations in MTOR (Table S1 ). We found that neuronal ciliogenesis was severely disrupted and that ciliary length was significantly decreased in FMCD brain tissue with cytomegalic neurons, compared to non-FMCD brain tissue ( Figures 1B-1D ). Also, defective neuronal ciliogenesis was observed in brain tissues from tuberous sclerosis complex (TSC) patients, which is another subtype of FMCD caused by a germline mutation in TSC2 leading to the hyperactivation of MTOR kinase (Figures S1A-S1D; Table S1 ). These results suggest that defective neuronal ciliogenesis is highly associated with FMCDs.
Next, to investigate whether brain somatic mutations in MTOR are causative for defective neuronal ciliogenesis, we generated in vitro and in vivo models of brain somatic mutations in MTOR. Brain somatic mutations in MTOR residue p.Cys1483 have been recurrently found in FMCD patients, including those with FCD and HME (D'Gama et al., 2015; Lee et al., 2012a; Lim et al., 2015) . An MTOR p.Cys1483Arg somatic mutation has also been found in FCD patients and characterized in vitro as an mTOR kinase-activating mutation (Lim et al., 2015) . Two independent studies have reported an MTOR p.Cys1483Tyr mutation in HME, which also appears to be an activating mutation (D'Gama et al., 2015; Lee et al., 2012a) . We also found an HME patient with an MTOR p.Cys1483Tyr somatic mutation in our cohort using deep targeted sequencing, followed by biological validation of whether malpositioned cytomegalic neurons can carry the MTOR p.Cys1483Tyr somatic mutation (Figures  1A and S2A-S2E; Table S1 ). However, this mutation has not been fully characterized in vitro and in vivo. Thus, to explore whether the MTOR p.Cys1483Tyr mutation causes hyperactivation of mTOR kinase, we first transiently transfected MTOR wildtype or mutant plasmids into human embryonic kidney 293T cells (HEK293T). We then performed western blot analysis and found that the MTOR p.Cys1483Tyr mutation induced a robust increase in P-S6 protein without affecting the expression level of MTOR protein itself, compared to MTOR wild-type ( Figure S2F ). We also pulled down FLAG-tagged MTOR wild-type and p.Cys1483Tyr protein from HEK293T cells expressing each MTOR construct and performed MTOR kinase assay in vitro. We found that MTOR p.Cys1483Tyr robustly increased kinase activity ( Figure S2G ). Furthermore, to test whether somatic mutation of endogenous MTOR protein induces hyperactivation of the mTOR pathway, we modeled MTOR c.4448G > A using homology-directed repair (HDR)-mediated genome editing with the CRISPR-Cas9 system. We generated a genome-edited NIH/3T3 cell line carrying the monoallelic Mtor c.4448G > A mutation (Figures S2H-S2K ; Table S2 ). We found that phosphorylation of S6 was significantly increased in mutant cells ( Figure S2L ). Taken together, these results indicated that the brain somatic mutation MTOR p.Cys1483Tyr induces hyperactivation of mTOR kinase.
Next, we examined whether expression of the MTOR p.Cys1483Tyr somatic mutation in the developing cortex is sufficient to cause cortical dyslamination, spontaneous behavioral seizures, and cytomegalic neurons, which are commonly observed in FMCD patients, including HME, FCD, and TSC (Foldvary-Schaefer et al., 2004; Lim and Crino, 2013) . To model a somatic activating mutation in MTOR during cortical development, we performed in utero electroporation to introduce pCIG-MTOR wild-type or p.Cys1483Tyr-IRES-EGFP plasmids into the focal cortical area at embryonic day 14 (E14), when the labeled neurons located to cortical layers II-IV (Tabata and Nakajima, 2001 ). We performed immunostaining and western blot analysis for P-S6 and MTOR protein in mouse brain tissues electroporated with MTOR wild-type and p.Cys1483Tyr constructs . We observed a significant increase in P-S6 protein in MTOR p.Cys1483Tyr-expressing mice brain tissue, compared to MTOR wild-type-expressing mice brain tissue (Figures S3A-S3C ). Also, we found no significant difference in the expression levels of MTOR protein between MTOR wild-typeand p.Cys1483Tyr-expressing neurons ( Figure S3A ). We then measured the distribution of radially migrating neurons and cortical lamination at E18, 4 days after electroporation. Compared with MTOR wild-type-expressing mice, MTOR p.Cys1483Tyr-expressing mice showed disruption of cortical layers II-IV upon staining for Cux1 (cut-like homeobox 1), as well as aberrant distribution of GFP-positive neurons throughout the cortex (Figures 2A-2C ). However, there were no significant differences in the intensity of other layer markers, such as Ctip2 (COUP-TF-interacting protein 2) (a marker for layer V) and Tbr1 (T-box, brain 1) (a marker for layer VI) (Figures S3D, S3E, S3G, and S3H) . Also, there were no significant changes in the identities of electroporated neurons corresponding to Cux1, Ctip2, and Tbr1 ( Figures 2D, S3F , and S3I). Next, we sought to determine whether focal cortical expression of MTOR p.Cys1483Tyr is sufficient to induce spontaneous behavioral seizures and cytomegalic neurons. Following in utero electroporation at E14, we selected GFP-expressing pups at birth (postnatal day 0, P0). After weaning, we monitored these mice for seizures using video recordings (12 hr/day) and electroencephalography (EEG) recordings (6 hr/day). Thirteen of the 14 (93.3%) mice expressing MTOR p.Cys1483Tyr showed spontaneous seizures and epileptic discharges, including high-voltage fast activities ( Figures 2E and 2F ). In contrast, control mice expressing MTOR wild-type showed no behavioral or electrographic seizures ( Figures 2E and 2F ). Furthermore, we measured the soma size of MTOR p.Cys1483Tyr-expressing neurons, compared with that of MTOR wild-type-expressing neurons, and found that soma size was increased in MTOR p.Cys1483Tyr-expressing neurons (Figures 2G and 2H) . After the mice (>P56) were injected daily via an intraperitoneal route with 10 mg/kg of rapamycin, an mTOR inhibitor, for 2 weeks, the increased soma size was significantly rescued (Figures 2G and 2H) . These data indicated that our mouse model of the somatic activating mutation MTOR p.Cys1483Tyr can recapitulate clinical and pathological phenotypes common among FMCD patients, including cortical dyslamination, seizures, and cytomegalic neurons.
To determine whether somatic activating mutations in MTOR affect the formation of primary cilia, we performed (D) Bar graph shows the length of primary cilia (non-FMCD, n = 32 cilia; HME 255, n = 19 cilia; FCDII 4, n = 17 cilia; FCDII 56, n = 9 cilia; FCDII 254, n = 14 cilia; FCDII 339, n = 10 cilia; **p < 0.01, ***p < 0.001, and ****p < 0.0001; one-way ANOVA with Bonferroni's multiple comparison tests). All data are presented as mean ± SEM. See also Figures S1 and S2 and Table S1. (C) Bar graph shows the normalized fluorescence intensities for Cux1 (wild-type, n = 5 mice; p.Cys1483Tyr, n = 6 mice; *p < 0.05 and **p < 0.01; Student's t test).
(legend continued on next page) immunostaining for primary cilia in MTOR p.Cys1483Tyr genome-edited NIH/3T3 cells, as well as cells transiently transfected with MTOR p.Cys1483Tyr plasmid after serum-starved conditions for 24 hr. MTOR mutant cells showed a robust decrease in ciliary length and number of ciliated cells, as labeled with any one of several ciliary markers, including Arl13b (ADP-ribosylation factor-like protein 13B), Ac-tub (acetylated tubulin), and GT335 (polyglutamylated tubulin) ( Figures S4A-S4C ). Treatment with the mTOR inhibitors torin-1 (200 nM) and rapamycin (200 nM) during serum-starved conditions for 24 hr restored ciliogenesis ( Figures 3A-3C ). Consistent with these data, wild-type NIH/3T3 cells transiently transfected with the MTOR mutant plasmid also showed defective ciliogenesis rescued by rapamycin treatment (Figures S4D-S4F ). We then examined whether MTOR p.Cys1483Tyr somatic mutation disturbs neuronal ciliogenesis in vivo. To do so, we performed immunostaining for the neuronal cilia marker ACIII (adenylyl cyclase type 3) in brain slices from MTOR p.Cys1483Tyr-expressing mice (>P56) presenting cortical dyslamination, seizures, and cytomegalic neurons. Compared with MTOR wild-type-expressing neurons, we found that the formation of neuronal primary cilia was markedly reduced in MTOR p.Cys1483Tyr-expressing neurons ( Figures  3D and 3E ). Similar to the in vitro results, intraperitoneal injection of rapamycin (10 mg/kg/day) for 2 weeks rescued the defective neuronal ciliogenesis in MTOR p.Cys1483Tyr-expressing neurons ( Figures 3D and 3E) .
We recently reported on another somatic activating mutation in MTOR, MTOR p.Leu2427Pro, that was found in patients with FCD and caused FMCD-related phenotypes in vivo (Lim et al., 2015) . To test whether this somatic mutation also disrupts ciliogenesis, we transfected the pCIG-MTOR p.Leu2427Pro-IRES-EGFP plasmid into wild-type NIH/3T3 cells and performed immunostaining for Ac-tub and Arl13b under serum-starved conditions. In line with results obtained with MTOR p.Cys1483Tyr-expressing cells, we observed defective ciliogenesis in MTOR p.Leu2427Pro-expressing cells, which was rescued by treatment with rapamycin (200 nM) under serum-starved conditions ( Figures S4D-S4F ). Moreover, we performed in utero electroporation of a pCIG-MTOR p.Leu2427Pro-IRES-EGFP plasmid into the developing mouse cortex and observed a significant decrease in the number of ciliated neurons in MTOR p.Leu2427Pro-expressing mice (>P56). Also, treatment with rapamycin (10 mg/kg per day) for 2 weeks rescued the defective neuronal ciliogenesis caused by MTOR p.Leu2427Pro-expression ( Figures S4G and S4H ). Taken together, these results suggest that brain somatic activating mutations in MTOR, which are causative for FMCDs, disrupt the formation of neuronal primary cilia.
Brain Somatic Mutation in MTOR Leads to Impaired Autophagy and Aberrant Accumulation of OFD1 Centriolar Satellite Protein The mTOR kinase is a negative regulator of autophagy (Laplante and Sabatini, 2012) . Interestingly, a recent study reported that autophagy promotes ciliogenesis at the cellular level by removing the autophagy substrate OFD1 from centriolar satellites (Tang et al., 2013) . OFD1 is a key regulator of ciliogenesis at centrioles, and inherited mutations in the OFD1 gene cause ciliopathies, such as oral-facial-digital syndrome and Joubert syndrome (Coene et al., 2009; Ferrante et al., 2001; Singla et al., 2010b) . Thus, we hypothesized that inhibition of autophagy caused by the MTOR somatic mutation would cause an aberrant accumulation of OFD1 at centriolar satellites, thereby potentially disrupting neuronal ciliogenesis. To test our hypothesis, we performed western blot analysis to examine whether MTOR mutant cells show an increase in OFD1 or inhibition of autophagy as marked by decreases in LC3-II and increases in p62 protein.
Compared with wild-type NIH/3T3 cells, serum-starved MTOR mutant cells showed increased OFD1 protein, decreased LC3-II, and increased p62 levels, reflective of autophagy inhibition ( Figure S5A ). The mTOR inhibitors torin-1 (200 nM) and rapamycin (200 nM) rescued the aberrant increases in OFD1, as well as the autophagy deficiency, in MTOR mutant cells ( Figure S5A ). Next, we performed immunostaining for p62 and OFD1. Consistent with results of western blot analyses, we observed significant increases in the number of p62 puncta in the cytoplasm of MTOR mutant cells, as well as MTOR p.Cys1483Tyr-expressing neurons of our mouse model (>P56) (Figures 4A-4D ). We also observed an increase in p62 puncta in neurons expressing another MTOR somatic activating mutation, p.Leu2427Pro ( Figures S5B and S5C ). In addition, treatment with 40 mM chloroquine (CQ), an autophagy inhibitor, under serum-starved conditions significantly decreased the number of primary cilia in wild-type NIH/3T3 cells, while there was no significant change in ciliogenesis in MTOR mutant cells ( Figures S5D-S5F ). Further, although OFD1 was only located at centrioles labeled with acetylated and g-tubulin in wild-type cells under serum-starved conditions, we noted aberrant accumulation of OFD1 at centriolar (D) Bar graph shows the percentage of Cux1-positive electroporated cells (wild-type, n = 5 mice; p.Cys1483Tyr, n = 6 mice; *p < 0.05 and **p < 0.01; Student's t test). (E) Spontaneous seizures were observed in mice expressing MTOR p.Cys1483Tyr and wild-type, based on the video-EEG recordings (wild-type, n = 8 mice; p.Cys1483Tyr, n = 15 mice). (F) EEG recording of ictal discharges from an MTOR p.Cys1483Tyr-carrying mouse. The ictal discharges with convulsive seizure are divided into three phases (tonic, clonic, and postictal). A detailed analysis of each phase corresponding to the blue bar is shown with an expanded scale. The EEG pattern of tonic and clonic phases (blue bars #1 and #2) shows low-amplitude, high-frequency polyspikes and a relatively high-amplitude, rhythmic pattern, respectively. The EEG pattern in the postictal phase (blue bar #3) represents the synchronized attenuation of amplitude. LF, left frontal lobe; RF, right frontal lobe; LT, left temporal lobe; RT, right temporal lobe. satellites around the centriole in MTOR mutant NIH/3T3 cells ( Figures 4E-4G ). These data suggest that the MTOR somatic mutations found in FMCD patients cause the inhibition of autophagy and aberrant accumulation of OFD1 at centriolar satellites, implying that failure of autophagy-mediated degradation of OFD1 may be responsible for defective neuronal ciliogenesis.
In addition to autophagy, MTOR can regulate the cell cycle and actin cytoskeletal rearrangement (Fingar et al., 2004; Jacinto et al., 2004; Sarbassov et al., 2004) , which can impact the formation of primary cilia: for example, entry into the cell cycle induces the disassembly of primary cilia (Nigg and Stearns, 2011) . To examine whether the MTOR p.Cys1483Tyr somatic mutation disrupts ciliogenesis by dysregulating the cell cycle, we performed immunostaining for Ki67, an indicator of cell proliferation. We found that there was no significant difference in the percentage of Ki67-positive cells between wild-type and MTOR mutant NIH/3T3 cells under untreated and serum-starved conditions (Figures S5G and S5H) . Then, we examined the cell cycle of MTOR p.Cys1483Tyr-carrying neurons in vivo at E16 by performing Ki67, PH3 (phospho-histone H3), and BrdU (bromodeoxyuridine) staining. We injected BrdU (100 mg/kg) intraperitoneally 2 hr before brain preparation. As a result, we found that the percentage of electroporated neurons positive for each marker was not significantly changed in MTOR p.Cys1483Tyr-expressing mice, compared to MTOR wild-type-expressing mice ( Figures  S5I-S5N ). Meanwhile, stabilization of the actin cytoskeleton negatively regulates ciliogenesis, whereas cytochalasin D, an inhibitor of actin polymerization, promotes ciliogenesis by destabilizing the actin cytoskeleton (Cao et al., 2012; Kim et al., 2010 Kim et al., , 2015 Sharma et al., 2011) . We found that treatment with cytochalasin D (100 nM) did not induce ciliogenesis in MTOR mutant cells, compared with wild-type NIH/3T3 cells (Figures S5O and S5P) . These results suggest that cell-cycle abnormalities and actin stabilization are not associated with the disruption of ciliogenesis caused by MTOR p.Cys1483Tyr somatic mutation.
Next, we examined whether the autophagy process is inhibited and whether OFD1 protein levels are aberrantly increased in FMCD brain tissues. We performed immunostaining (C) Bar graph shows the lengths of primary cilia (wild-type with vehicle, n = 37 cilia; wild-type with torin-1, n = 43 cilia; wild-type with rapamycin, n = 29 cilia; p.Cys1483Tyr with vehicle, n = 16 cilia; p.Cys1483Tyr with torin-1, n = 42 cilia; p.Cys1483Tyr with rapamycin, n = 67 cilia; **p < 0.01 and ****p < 0.0001; one-way ANOVA with Bonferroni's multiple comparison tests). (D) Immunostaining for ACIII with DAPI co-staining in affected cortical regions of MTOR wild-type-or p.Cys1483Tyr-expressing mice (>P56). Scale bars, 15 mm.
(E) Bar graph shows the percentage of GFP-positive ciliated cells (wild-type with vehicle, n = 4 mice; wild-type with rapamycin, n = 4 mice; p.Cys1483Tyr with vehicle, n = 5 mice; p.Cys1483Tyr with rapamycin, n = 5 mice; **p < 0.01; one-way ANOVA with Bonferroni's multiple comparison tests). All data are presented as mean ± SEM. See also Figure S4 . (legend continued on next page) of p62 and observed marked increases in p62 puncta in cytomegalic neurons in brain tissue from HME and FCD patients (Figures 4H and 4I) . Inhibited autophagy was also observed by immunostaining of p62 in brain tissue from TSC patients (Figures 4H and 4I) . Consistent with our findings, a recent report indicated that defective autophagy is associated with dysmorphic neurons in FCD and TSC brain specimens (Yasin et al., 2013) . In western blot analysis of OFD1, we found significantly greater accumulation of the OFD1 protein in brain tissue from FMCD patients with HME, FCD, and TSC, compared to non-FMCD brain tissue (Figure 4J) . These results suggest that brain somatic mutation in MTOR leads to impaired autophagy and aberrant accumulation of OFD1 centriolar satellite protein.
The Aberrant Accumulation of OFD1 Caused by Impaired Autophagy Is Responsible for Defective Neuronal Ciliogenesis
To test the possibility of whether autophagy-mediated degradation of OFD1 is required for neuronal ciliogenesis, we sought to determine whether knockdown of Ofd1 would restore ciliogenesis in MTOR p.Cys1483Tyr mutant cells. After selecting the most efficient short hairpin RNA (shRNA) sequence against Ofd1 (Ofd1 shRNA #3) ( Figure S6A ), we transfected the Ofd1 shRNA plasmid containing a GFP reporter into MTOR mutant NIH/3T3 cells and found that the accumulation of OFD1 at centriolar satellites disappeared under serum-starved conditions (Figures S6B and S6C) . Furthermore, we found that the knockdown of Ofd1 was able to restore ciliogenesis in MTOR mutant cells (Figures 5A and 5B). Importantly, to verify whether knockdown of Ofd1 restores neuronal ciliogenesis in vivo, we performed in utero electroporation of the p.Cys1483Tyr mutant plasmid with Ofd1 shRNA. Consistent with the in vitro results, knockdown of Ofd1 rescued defective neuronal ciliogenesis in MTOR p.Cys1483Tyr-expressing neurons (>P56) ( Figures 5C, 5D , and S6D). These data indicate that MTOR somatic mutation induces aberrant accumulation of OFD1 and that the accumulation of OFD1 is responsible for defective neuronal ciliogenesis.
Next, we examined whether the impaired autophagy caused by MTOR somatic mutation accounts for OFD1 accumulation and defective neuronal ciliogenesis. The autophagy-related protein ATG5 is essential for formation of the autophagosome, and ATG5 deficiency impairs autophagy (Mizushima et al., 1998 Suzuki et al., 2001) . ATG5 is also critical for early brain development, in which it is involved in cortical neurogenesis and astrocyte differentiation Wang et al., 2014) . A recent study showed that ATG5 deficiency disrupts ciliogenesis in murine fibroblasts and kidney cells (Tang et al., 2013) . Thus, to test whether autophagy mediates neuronal ciliogenesis by degrading OFD1 in vivo, we performed in utero electroporation of an Atg5 shRNA plasmid containing a GFP reporter at E14 and found that it was able to reduce the expression level of Atg5 protein in the developing cortex (E16), as measured by immunostaining and western blot analysis of brain lysates (Figures 5E, S6E, and S6F) . Also, we observed increased p62 puncta in the cytoplasm of Atg5 shRNA-expressing neurons (>P21) ( Figures  S6G and S6H) . Furthermore, we found significant perturbation of neuronal ciliogenesis in Atg5 shRNA-expressing neurons (>P56) (Figures 5F and 5G) and increased OFD1 protein levels in lysates of affected cortical areas ( Figure 5E ). Collectively, these results suggest that the MTOR somatic mutations found in FMCD patients induce aberrant accumulation of OFD1 by impairing autophagy, thereby eliciting defective neuronal ciliogenesis.
Disruption of Autophagy-Mediated Neuronal Ciliogenesis Leads to Cortical Dyslamination in FMCDs by Disturbing Wnt Signaling
We further examined whether the disruption of neuronal ciliogenesis contributes to pathological phenotypes of FMCDs, such as cortical dyslamination, cytomegalic neurons, and epilepsy, which were successfully phenocopied in MTOR p.Cys1483Tyr-expressing mice. To do this, we examined which phenotype could be alleviated by the restoration of neuronal ciliogenesis upon Ofd1 knockdown in MTOR p.Cys1483Tyr-expressing mice. Surprisingly, Ofd1 knockdown in MTOR p.Cys1483Tyr-expressing mice (E18) considerably restored defective neuronal migration and cortical dyslamination, compared to MTOR p.Cys1483Tyr-expressing mice ( Figures S6I-S6K ). This restoration of neuronal migration and cortical dyslamination was also observed in adult mouse brains expressing MTOR p.Cys1483Tyr with Ofd1 shRNA, especially in cortical layer V to layers II-IV (Figures 6A and 6B) . However, Ofd1 knockdown did not affect spontaneous behavioral seizures or cytomegalic neurons present in the MTOR p.Cys1483Tyr-expressing mice ( Figures S6L-S6P ). These results indicate that defective neuronal ciliogenesis elicited by somatic activating mutation in MTOR underlies cortical dyslamination, but not behavioral seizures and dysmorphic neurons.
Additionally, the results implied that autophagy-mediated neuronal ciliogenesis, compromised by MTOR somatic mutation, promotes proper cortical lamination. To test this, we further examined whether the disruption of autophagy-mediated neuronal ciliogenesis is responsible for the abnormal neuronal migration and cortical dyslamination observed in FMCDs. We knocked down Atg5 in developing cortical neurons in vivo and found that knockdown of Atg5 resulted in a decrease in the number of GFP-positive neurons in the upper cortical plate and a robust increase in the number of GFP-positive neurons in the lower cortical plate, suggestive of defective migration ( Figures 6C and 6D ). In addition, we performed immunostaining for Cux1 (a marker for the cortical layer II-IV) (H) Immunostaining for p62 and NeuN with DAPI co-staining in brain tissue of FMCD patients, including HME, FCD, and TSC. Scale bars, 30 mm.
(I) Bar graph shows the Manders' overlap coefficient (non-FMCD, n = 15 cells; HME 255, n = 18 cells; FCDII 4, n = 12 cells; FCDII 56, n = 24 cells; FCDII 254, n = 11 cells; FCDII 339, n = 12 cells; TSC 256, n = 13 cells; TSC 264, n = 21 cells; TSC 357, n = 23 cells; *p < 0.05, **p < 0.01, and ***p < 0.001 compared with non-FMCD; one-way ANOVA with Bonferroni's multiple comparison tests). (J) Western blot analysis for OFD1 in lysates from patient brain tissues. Band intensities were quantified (n = 4 experiments; *p < 0.05, **p < 0.01, and ***p < 0.001; one-way ANOVA with Bonferroni's multiple comparison tests). All data are presented as mean ± SEM. See also Figure S5 . and found that cortical lamination was disrupted in mice upon knockdown of Atg5 (Figures 6C and 6E ). As expected, knockdown of Atg5 did not result in either seizures or cytomegalic neurons (Figures S6Q-S6S) . Thus, these data suggest that autophagy-mediated neuronal ciliogenesis by degradation of OFD1 is critical for proper neuronal migration and cortical lamination and, when disrupted by MTOR somatic mutation, causes cortical dyslamination in FMCDs. Next, we investigated the mechanism by which impaired neuronal ciliogenesis causes disrupted migration of cortical neurons. Primary cilia integrate various signaling pathways, including Wnt, Shh, PDGF, and GPCR signaling (Bangs and Anderson, 2016; Corbit et al., 2005; Hilgendorf et al., 2016 ; May-Simera and Kelley, 2012). Among these signaling (B) Distribution of GFP-positive neurons in each cortical layer (wild-type, n = 4 mice; p.Cys1483Tyr with scrambled, n = 6 mice; p.Cys1483Tyr with Ofd1 knockdown, n = 7 mice; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; one-way ANOVA with Bonferroni's multiple comparison tests). (C) Immunostaining for Cux1 with DAPI co-staining in cortical regions at E18. Scale bars, 100 mm. (D) Bar graph showing the percentage of GFP-positive cells reflecting the distribution of electroporated cells within the developing mouse neocortex at E18 (scrambled, n = 4 mice; Atg5 knockdown, n = 6 mice; *p < 0.05, **p < 0.01, and ***p < 0.001; Student's t test).
(E) Bar graph shows the normalized fluorescence intensities for Cux1 (scrambled, n = 4 mice; Atg5 knockdown, n = 6 mice; *p < 0.05 and ****p < 0.0001; Student's t test). All data are presented as means ± SEM. See also Figure S6 . (D) Bar graph shows the Manders' overlap coefficient (wild-type, n = 3 mice; p.Cys1483Tyr, n = 4 mice; p.Cys1483Tyr with Ofd1 knockdown, n = 6 mice; *p < 0.05, **p < 0.01, and ***p < 0.001; one-way ANOVA with Bonferroni's multiple comparison tests).
(legend continued on next page) pathways, the Wnt pathway has been implicated in neuronal radial migration and cerebral cortical development (Boitard et al., 2015; Corbit et al., 2008; Gerdes et al., 2007; Munji et al., 2011) : for example, transient downregulation of canonical Wnt/b-catenin signaling by an increase of non-canonical Wnt signaling at the upper subventricular zone (upSVZ) underlies multipolar to bipolar transition of migrating neurons, which is necessary for proper cortical lamination (Boitard et al., 2015) . To test whether impaired neuronal ciliogenesis abrogates Wnt signaling, we co-electroporated a canonical (M38-TOPdGFP) or non-canonical (CHOPdGFP) Wnt signaling-dependent reporter with MTOR wild-type or p.Cys1483Tyr-expressing plasmids at E14. As a result, we observed aberrant activation of canonical Wnt signaling, whereas non-canonical Wnt signaling was significantly inactivated at the upSVZ of MTOR p.Cys1483Tyr-expressing mice (E16), compared with MTOR wild-type-expressing mice (Figures 7A-7D ). Then, we analyzed the polarity of neurons residing in the intermediate zone (IZ) of the developing mice cortex (E18) by measuring the number of primary processes and branch nodes. We found that, while most wild-type neurons showed bipolar stages in IZ, MTOR p.Cys1483Tyr neurons showed multipolar stages with an increased number of branch processes (Figures S7A-S7C ). Next, we tested whether the rescue of neuronal cilia by Ofd1 knockdown could restore dysregulated Wnt signaling and defective neuronal polarity. We found that MTOR p.Cys1483Tyr-expressing mice with Ofd1 knockdown showed transient downregulation of the canonical Wnt pathway and upregulation of the noncanonical Wnt pathway in the upSVZ accompanied by the restoration of impaired neuronal polarity, similar to MTOR wild-type-expressing mice ( Figures 7A-7D and S7A-S7C ). These results suggest that dysregulation of the cilia-mediated Wnt pathway by MTOR somatic activating mutation may be critical for neuronal migration and proper cortical development. Thus, we further examined whether the restoration of inactivated non-canonical Wnt pathway signaling is sufficient to rescue defective neuronal migration in MTOR p.Cys1483Tyr-expressing mice. To do so, we co-electroporated a Wnt5a-expressing vector, a ligand for non-canonical Wnt pathway signaling, with MTOR p.Cys1483Tyr-expressing plasmid, and observed the restoration of defective neuronal migration, as marked by an increase in the number of electroporated neurons in the upper cortical plate and a decrease in the number of electroporated neurons in the lower cortical plate ( Figures  7E, 7F and S7D-S7J ). These results demonstrated that defective neuronal ciliogenesis abrogates Wnt signaling in the SVZ, thereby disrupting proper cortical lamination. Taken together, all of these results suggest that disruption of autophagy-mediated neuronal ciliogenesis leads to cortical dyslamination in FMCDs with brain somatic mutations in MTOR by disturbing Wnt signaling.
DISCUSSION
Herein, we outlined the molecular genetic mechanism of how brain somatic mutations in MTOR lead to focal cortical dyslamination commonly found in patients with FMCDs. We observed severely defective neuronal ciliogenesis not only in FMCD patients with brain somatic mutation in MTOR, but also in a genome-edited cell line and an in utero electroporated mouse model carrying somatic activating mutation in MTOR. Next, we observed that inhibition of autophagy by MTOR somatic activating mutation induced the aberrant accumulation of OFD1 at centriolar satellites in the brain tissue of FMCD patients, as well as the in vitro and in vivo models, which resulted in defective neuronal ciliogenesis. Then, selective knockdown of Ofd1 was able to rescue disrupted neuronal ciliogenesis in the mouse model, and restoration of neuronal ciliogenesis alleviated cortical dyslamination. We further showed that defective neuronal ciliogenesis abrogated non-canonical Wnt signaling in the upSVZ, thereby disrupting cortical lamination. HME, FCD, and TSC are the most important causes of intractable epilepsy, developmental delay, and autism-spectrum disorder (Casanova et al., 2013; Palmini and Holthausen, 2013; Schwartzkroin and Walsh, 2000) . These conditions present with defective cortical lamination as a common pathological feature (Aronica et al., 2012) . Although these conditions are caused by genetic variations that lead to hyperactivation of the PI3K-AKT-mTOR pathway, the molecular mechanism underlying the defective cortical lamination remains poorly understood (Crino, 2016; D'Gama et al., 2015 D'Gama et al., , 2017 Lee et al., 2012a; Lim et al., 2015; Mirzaa et al., 2016; Møller et al., 2016; Nakashima et al., 2015) . Recently, Baek and colleagues reported that neural progenitors carrying an activating mutation in AKT3 exert a noncell-autonomous effect on the migration of neighboring neurons through effects on the secretion of Reelin (Baek et al., 2015) . How mutations autonomously affect neuronal migration, however, has yet to be clarified. Our study implies that defects in autophagy-mediated neuronal ciliogenesis underlie the cellautonomous migration of mutation-carrying neurons, which may be followed by non-cell-autonomous effects on the migration of neighboring neurons. Interestingly, we also observed defective ciliogenesis and impaired autophagy of GFP-negative neurons adjacent to GFP-positive neurons with MTOR mutations (Figures 3D and 4C ), implying that non-cell-autonomous effect exerted by somatic mutation in MTOR might be associated with this phenomenon. Non-cell-autonomous effect of somatic mutations in MTOR would be an interesting subject worthy of future study.
While neuronal misplacement has frequently been found to be associated with seizures in FMCDs, whether cortical dyslamination is necessary for epileptogenesis in FMCDs is not as clear. Our results indicated that cortical dyslamination in FMCD patients with brain somatic mutations activating the mTOR (E) Immunostaining showing the position of electroporated neurons in developing mouse neocortices (E18). Scale bars, 100 mm. (F) Bar graph showing the percentage of GFP-positive cells, reflecting the distribution of electroporated cells within the developing mouse neocortex at E18 (wildtype, n = 5 mice; p.Cys1483Tyr, n = 4 mice; p.Cys1483Tyr + Wnt5a, n = 5 mice; *p < 0.05, **p < 0.01, and ***p < 0.001; one-way ANOVA with Bonferroni's multiple comparison tests). All data are presented as mean ± SEM. See also Figure S7 . pathway is not necessary for epileptogenesis and neuronal cytomegaly. Consistent with our findings, Hsieh and colleagues recently demonstrated that spontaneous seizures do not require cortical dyslamination in an experimental model of FCD (Hsieh et al., 2016) . Although further studies will be necessary for elucidating how the small fraction of neurons with MTOR somatic mutation induce intractable seizures, our findings reflect a molecular mechanism of how brain somatic mutations in MTOR cell-autonomously induce the defective neuronal migration commonly found in patients with FMCDs.
Ciliopathy describes a group of human syndromic disorders that are caused by ciliary dysfunction, such as Bardet-Biedl syndrome (BBS), Joubert syndrome (JBTS), and orofaciodigital syndrome (OFD) (Reiter and Leroux, 2017) . It is well established that almost all underlying genetic causes for ciliopathies are inherited or de novo germline mutations in genes encoding proteins that localize to, or function within, the ciliary compartment, thereby affecting multiple organs (Reiter and Leroux, 2017) . However, in this study, we discerned that brain somatic mutations in a small subset of neurons are sufficient to cause severely defective neuronal ciliogenesis and that such somatic mutations result in dysfunction of neuronal cilia responsible for focal cortical dyslamination in FMCDs. Thus, our results imply that ciliopathies could also be caused by somatic mutations, in addition to inherited or de novo germline mutations. Consistent with this idea, Saitsu and colleagues recently reported that brain-specific somatic mutations in genes encoding ciliary proteins, such as Gli3 and Ofd1, can cause hypothalamic hamartoma (Saitsu et al., 2016) . Also, our study suggests that FMCDs caused by brain somatic mutations in mTOR pathway genes are a sporadic form of ciliopathy presenting focal cortical dyslamination.
Neuronal primary cilia are critical for neuronal migration during brain development (Guemez-Gamboa et al., 2014) . It was recently reported that primary cilia play a guiding role in the migration and placement of developing interneurons (Baudoin et al., 2012; Higginbotham et al., 2012 Higginbotham et al., , 2013 . Also, neuronal cilia-mediated signaling is essential for initial formation of radial progenitor scaffolds and, when disrupted, causes aberrant neuronal placement (Higginbotham et al., 2013) . Recently, primary cilia in radial glial cells were reported to be critical for brain ventricle morphogenesis and cortical development by regulating the mTORC1 pathway (Foerster et al., 2017) . However, the role for primary cilia in radially migrating pyramidal neurons remains unclear. Emerging studies implicate Wnt signaling, which also can be regulated by primary cilia, in neuronal radial migration and cerebral cortical development by promoting neuronal transition from a multipolar to bipolar phase (Boitard et al., 2015; Corbit et al., 2008; Gerdes et al., 2007; Munji et al., 2011) . Moreover, it has been shown that the maintenance of appropriate Wnt/ b-catenin signaling tone in cortical radial progenitors is necessary for cerebral cortical development (Nakagawa et al., 2017) . Like autophagy-deficient neurodevelopmental disorders, many ciliopathies present with defective neuronal migration (Guemez-Gamboa et al., 2014; Guo et al., 2015) . To date, however, whether neuronal autophagy and neuronal cilia work cooperatively for proper neuronal migration remains unexplored. Our study revealed a physiological role for autophagy-mediated neuronal ciliogenesis in neuronal migration and cortical lamination mediated by non-canonical Wnt signaling. Taken together, the results of our study not only shed light on a molecular mechanism underlying cortical dyslamination in patients with FMCDs, but also provide insights into the physiological role of autophagy-mediated neuronal ciliogenesis in the human brain.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Subject ascertainment Individuals with focal malformation of cortical development (FMCD), including FCD, TSC, and HME, who had undergone epilepsy surgery were identified through Severance Children's Hospital. Enrolled individuals met the study entry criteria for FMCD and underwent the extensive presurgical evaluations, including video-electroencephalography (EEG) monitoring, high-resolution MRI fluorodeoxyglucose (FDG)-PET, and subtraction ictal single-photon emission computed tomography (SPECT) co-registered to MRI (SISCOM) to localize anatomic lesions. The presurgical and surgical protocols have been published previously (Kim et al., 2011b; Lim et al., 2015) . The resection margin for epilepsy of the neocortical origin was defined by (i) the presence of a massive and exclusive ictal-onset zone confirmed by intracranial EEG; (ii) various interictal intracranial EEG findings including > 3/s repetitive spikes, runs of repetitive spike and slow wave discharges, localized or spindle-shaped fast activities, and electrodecremental fast activities; and (iii) the absence of the eloquent cortex. Complete resection was defined by resection of all areas with seizure-onset and irritative zones on intracranial EEG. The pathological diagnosis of the patients with FCDII was reconfirmed for this study. Non-FMCD brain specimen was collected from resection margin for epilepsy of an individual with Lennox-Gastaut syndrome (LGS). Clinical and molecular genetic information of individuals enrolled in this study is listed in Table S1 . Sample size was not predetermined. The study was performed and all human tissues were obtained in accordance with protocols approved by Severance Hospital and KAIST Institutional Review Board and Committee on Human Research. Informed consent from the parent of individuals with FMCD was obtained. Animals C57BL/6 or CD-1 mice (DBL, Korea) were used in experiments without sex discrimination, and they were housed in isolator cages with free access to food and water that were located in a room maintained at a constant temperature of 23 C on a 12-h light-dark cycle with lights off at 7:00 p.m. All of the mice used in this study were healthy mice with normal immune status and they were not involved in any previous test or drug treatment. All procedures were approved by KAIST Institutional Animal Care and Use Committee.
Cell culture HEK293T cell line (ATCC, USA) was cultured in DMEM (LM 001-05, Welgene, Korea) supplemented with 10% FBS (PK004-07, Welgene, Korea) and 1% penicillin/streptomycin at 37 C and 5% CO 2 . NIH/3T3 wild-type (ATCC, USA) and genome-edited MTOR p.Cys1483Tyr cell lines were cultured in DMEM (LM 001-05, Welgene, Korea) supplemented with 10% Bovine serum (16170078, Thermo, USA) and 1% penicillin/streptomycin at 37 C and 5% CO 2 . All cell lines tested negative for mycoplasma contamination, but have not been further authenticated. For western blot analysis and immunofluorescence, cells were seeded at 6-well plate (3506, Corning, USA) and 4-chambered slide (154917, Thermo, USA), respectively. To induce primary ciliogenesis, cells were incubated in serum-free DMEM for 24 hours after wash with serum-free DMEM. For plasmid DNA transient transfection, we used iN-fect in vitro transfection reagent (15081, Intron, Korea) according to manufacturer's protocol.
METHOD DETAILS
Targeted hybrid capture sequencing and bioinformatic analysis Targeted hybrid capture sequencing was performed as previously described (Lim et al., 2015) . In brief, we designed hybrid capture probe including MTOR using SureDesign online tools (Agilent Technologies). Target capture was carried out according to the manufacturer's protocol (Agilent Technologies). Then, we generated analysis-ready bam file using GATK ''Best Practice'' pipeline (BROAD institute). We aligned raw sequence from fastq file to the hg19/GRCh37 assembly of the human genome reference sequence using Burrows-Wheeler aligner (BWA) (BROAD institute). To identify de novo single nucleotide variants (SNVs) in brain sample, we utilized the MuTect algorithm (BROAD institute) which is designed for analyzing blood-brain paired sequencing datasets. We annotated identified variants with SnpEff program (Cingolani et al., 2012) . We then excluded 1) mutations with a mutant read < 4, allele frequency < 1% and total read depth < 100 3 to remove erroneous calls; 2) mutations with a putative low impact score; 3) mutations with a PolyPhen score < 0.9 and phastCons score < 0.9; and 4) mutations with allele frequency in ExAC database of east Asian population > 0.1%. Plasmids pcDNA3.1 Flag-tagged MTOR p.Cys1483Tyr plasmid and pCIG-MTOR p.Cys1483Tyr-IRES-EGFP plasmid were generated from MTOR wild-type inserted plasmid by site-directed mutagenesis described below in detail. Plasmids containing shRNA against mouse Ofd1 transcript and scrambled shRNA were purchased from QIAGEN (SureSilencing shRNA plasmid for mouse Ofd1) (km34866G, QIAGEN, USA). To estimate knockdown efficiency of Ofd1 shRNA, a pCIG-Ofd1:Myc-IRES-EGFP plasmid (24560, Addgene) (Singla et al., 2010a) was co-transfected with Ofd1 shRNA at HEK293T cell. To insert the sequence corresponding to Ofd1 knockdown (from U1 promoter start site to U1 termination site) into pCIG-MTOR p.Cys1483Tyr-IRES-EGFP plasmid, we utilized a restriction enzyme site for SfiI. The PCR fragments corresponding to sequences from scrambled shRNA or Ofd1 shRNA were inserted into the SfiI site of the pCIG-MTOR p.Cys1483Tyr-IRES-GFP plasmid using primer pairs, SfiI-U1-F; 5 0 -CAGAGGCC GAGGCCGCCTCGGCCCACTATAGG-3 0 and SfiI-U1-R; 5 0 -ATAGCTCAGAGGCCGAGGCGGCCGTGACAC-3 0 , resulting in the plasmid pCIG-MTOR p.Cys1483Tyr-IRES-EGFP with scrambled shRNA or Ofd1 shRNA. shRNA oligonucleotides against mouse Atg5 transcript (5 0 -GGACTGCAGAATGACAGAT-3 0 ) and scrambled shRNA sequence (5 0 -GGAATCTCATTCGATGCAT-3 0 ) were inserted into pSicoR-GFP plasmid (11579, Addgene) (Ventura et al., 2004) . The sequence for Atg5 shRNA was described previously (Kanamori et al., 2011) . To examine the Wnt signaling pathway, Wnt signaling-dependent reporter construct including M38 TOPdGFP (17114, Addgene) and pCLX-CHOP-dGFP (71299, Addgene) were used with pCIG-MTOR wild-type or p.Cys1483Tyr-IREStdTomato and pCIG-empty or Wnt5a-IRES-tdTomato plasmids.
Mutagenesis and cloning of MTOR mutant construct pcDNA3.1 Flag-tagged MTOR wild-type construct was kindly provided by K.-L. Guan at UCSD. This construct was used to generate MTOR p.Cys1483Tyr vector with a QuikChange II site-directed mutagenesis kit (200523, Stratagene, USA) . The primers for mutagenesis are as follows, sense; 5 0 -GCCGCATGCGCTACCTCGAGGCC-3 0 and antisense; 5 0 -GGCCTCGAGGTAGCGCATGCGGC-3 0 . For generating pCIG-MTOR p.Cys1483Tyr-IRES-GFP vector, we utilized pCIG2-C1 (modified from pCIG2) vector which was previously described (Lim et al., 2015) . Briefly, the annealed primer set (forward; 5 0 -AATTCCAATTGCCC GGGCTTAAGATCGATACGCGTA-3 0 and reverse; 5 0 -CCGGTACGC GTATCGATCTTAAGCCCGGGCAATTGG-3 0 ) was inserted into the EcoRI and XmaI of pCIG2 (CAG promoter-MCS-IRES-EGFP) to generate pCIG2-C1 with new restriction enzyme sites, MfeI and MluI. The PCR fragments corresponding to p.Cys1483Tyr mutated MTOR genes were subcloned into the MfeI and MluI sites of the pCIG2-C1 vector using the primer pairs, MTOR-MfeI-flag-F; 5 0 -GATCACAATTGTGGCCACCATGGACTACAAGGACGACGATGACAAGATGC-3 0 and MTORMluI-R; 5 0 -TGATCAACGCGTTTACCAGAAAGGGCACCAGCCAATATAGC-3 0 , resulting in the plasmid pCIG-MTOR p.Cys1483Tyr-IRES-EGFP.
Cas9 and guide RNA constructs
For screening of sgRNAs, we used a plasmid encoding Cas9-2A-mRFP-2A-PAC (Puromycin N-acetyl-transferase, puromycin resistance gene) and a plasmid encoding sgRNAs, both of which are from Toolgen (Seoul, South Korea). The sgRNA target sequences were manually designed based on PAM motif sequence (NGG) near the Mtor c.4448G and cloned into the vectors as previously described (Ramakrishna et al., 2014a) . Briefly, oligonucleotides containing each target sequence were synthesized (Bioneer, Seoul, South Korea) and annealed in vitro using a thermocycler. The vector was digested with BsaI restriction enzyme and ligated with the annealed oligonucleotides. Oligonucleotide sequences are listed in Table S2. T7E1 assay NIH/3T3 cells were co-transfected with plasmids encoding Cas9 and sgRNA targeting Mtor c.4448G site at a 1:2 weight ratio using Neon (Thermo, USA) according to the manufacturer's instructions. Three days after transfection, cells were subjected to the T7 endonuclease 1 (T7E1) assay. The T7E1 assay was performed as previously described (Kim et al., 2009 (Kim et al., , 2011a . Genomic DNA was isolated using the Wizard Genomic DNA purification Kit (A1120, Promega, USA) according to the manufacturer's instructions. The region including the nuclease target site was nested PCR-amplified using primer pairs, forward; 5 0 -TGCATTAAGAATGCGGAGAA-3 0 , reverse; 5 0 -AGGGTCACATGGCTCTTCTG-3 0 . The amplicons were denatured by heating and annealed to allow heteroduplex DNA formation, which was treated with 5 units of T7 endonuclease 1 (M0302, NEB, USA) for 20 minutes at 37 C followed by analysis using 2% agarose gel electrophoresis. Mutation frequencies were calculated as previously described based on the band intensities using ImageJ software and the following equation (Guschin et al., 2010) : mutation frequency (%) = 100
where the fraction cleaved is the total relative density of the cleavage bands divided by the sum of the relative density of the cleavage bands and uncut bands.
Preparation of single-stranded oligodeoxynucleotides (ssODN)
A KpnI restriction enzyme site was incorporated at the desired point mutation region for screening homology-directed repair-mediated mutated clones by Restriction Fragment Length Polymorphism (RFLP) assay. The ssODN donor template (5 0 -CAAACAAGGAA GACCCGGAGCTGATGCTGGGCCGAATGCGGTACCTCGAAGCCTTGGGGGAATGGTGAGCTTCACTGGAGTGATGACCTG-3 0 ) was synthesized and purified by PAGE (Bioneer, South Korea). ssODN was diluted with RNase free water to 100 mM, divided into aliquots and stored at À20 C. ssODN was electroporated into NIH/3T3 cells using the NEON transfection system (Thermo, USA).
Generation of knock-in clones NIH/3T3 cell was co-transfected with plasmid encoding Cas9, sgRNA targeting Mtor c.4448G and ssODN donor DNA. Cas9 encoding plasmid and sgRNA were transfected at a 1:2 weight ratio using Neon. In the case of ssODN donor DNA, 500 pmol of ssODN is used per reaction. One day after transfection, cells were subjected to puromycin selection (1mg/mL) for three days. Then, cells were trypsinized and resuspended in DMEM medium and seeded into 96-well plates at an average density of 0.25 cells/well. Twenty days after the cell seeding, each well was microscopically evaluated and single cell-derived round colonies were selected (Ramakrishna et al., 2014b) . Each selected colony was individually trypsinized and replated into 24-well plates. Six days after the subculture, genomic DNA was isolated from each clone and subjected to the RFLP analysis and Sanger sequencing. Single-cell derived knock-in clones are screened by performing genomic DNA and subjected to PCR amplification with primers flanking the target site, forward; 5 0 -CTTCACCACGTGCTCTCAGT-3 0 , reverse; 5 0 -GGCTCACAGCCCCAATTCTACT-3 0 . PCR amplicons were digested with KpnI. Sequencing of the genomic region including the target sequence was performed as previously described (Kim et al., 2011a; Ramakrishna et al., 2014a) . Briefly, PCR amplicons that included nuclease target sites were cloned into the T-Blunt vector (Promega, USA) and the cloned plasmids were sequenced using the M13 Forward primer (5 0 -GTAAAACGACGGCCAGT-3 0 ).
Pharmacological studies
To see whether MTOR p.Cys1483Tyr mutation influences stability of actin cytoskeleton, we treated 100nM cytochalasin D (CytD) (C2618, Sigma, USA) resuspended in dimethyl sulfoxide (DMSO) in cells with media containing 10% bovine serum for 24 hours.
To inhibit autophagy, we treated 20uM chloroquine (C6628, Sigma, USA), an inhibitor for autophagy, in cells with serum-free media for 24 hours. To inhibit the MTOR kinase activity, we treated 200nM rapamycin (553210, Calbiochem, USA) or 200nM torin-1 (475991, Merck Millipore, USA) in cells with serum-free media for 24 hours.
In vitro MTOR kinase assay
In vitro MTOR kinase assay was performed as previously described (Lim et al., 2015) . The kinase activity of MTOR was assayed using a K-LISA mTOR activity kit (CBA055, Calbiochem, USA) according to the manufacturer's protocol. Briefly, transfected cells were lysed with TBS containing 1% Tween 20 and Halt protease and phosphatase inhibitor cocktail (78440, Thermo Scientific, USA). 1mg of total lysate was pre-cleared by adding 15 ml of protein G beads (10004D, Life technologies, USA) and incubated for 15 minutes at 4 C. Anti-Flag antibodies (8146, Cell signaling Technology, USA, 1/250 dilution) were added to the pre-cleared lysate and incubated overnight at 4 C. Then, 50 ml of protein G beads were added and incubated for 90 minutes at 4 C. The supernatant was carefully discarded. The pelleted beads were washed 4 times with 500 ml of lysis buffer and 1 time with 1 3 kinase buffer supplied with the K-LISA mTOR activity kit. The pelleted beads were resuspended in 50 ml of 2 3 kinase buffer and 50 ml of mTOR substrate (p70S6K-GST fusion protein), followed by incubation for 30 minutes at 30 C. The reaction mixture was incubated in a glutathione-coated 96-well plate and incubated for 30 minutes at 30 C. The phosphorylated substrate was detected using anti-p70S6K-T389 antibody (JA9357, Merck Millipore, Germany, 1/1,000 dilution), HRP antibody-conjugate and TMB substrate. Relative fluorescence intensities were measured by reading the absorbance at 450 nm.
Laser-capture microdissection with the subsequent Sanger sequencing Laser-capture microdissection with the subsequent Sanger sequencing for validation of MTOR c.4448G > A mutation was performed as previously described (Lim et al., 2015) . Briefly, freshly frozen brain sample was fixed in phosphate-buffered 4% paraformaldehyde for overnight at 4 C. The next day, fixed tissue was submerged in 30% sucrose for cryoprotection at 4 C until they settle down to bottom. Cryoprotected tissue was embedded in gelatin block (7.5% gelatin in 10% sucrose/PB) and stored at À80 C. Cryostatcut sections (10 mm thick) were collected and placed on glass slides. After immunostaining for phosphorylated S6 and NeuN, phosphorylated S6-immunoreactive cytomegalic neurons (n = $40) were microdissected with PALM laser capture system (Carl Zeiss, Germany) and collected in the adhesive cap (Carl Zeiss, Germany). Genomic DNA was extracted from collected neurons using QiAamp DNA microkit under manufacturer's isolation of genomic DNA from LCM tissues (QIAGEN, USA). Genomic DNA extracted from phosphorylated S6-immunoreactive cytomegalic neurons was used for validating MTOR c.4448G > A mutation. This region was amplified by PCR using targeted primer set and high-fidelity PrimeSTAR GXL DNA polymerase (Takara, Japan). The detailed sequence of the primer set is as follows: forward; 5 0 -CCTCACAGCAGTCTTTCTTTCC-3 0 and reverse; 5 0 -CATGCCATCATTCTAG GAAGC-3 0 . Amplified PCR product was purified with MEGA quick spin total fragment DNA purification kit (Intron, Korea). Then, we performed Sanger sequencing (Cosmogenetech, Korea) with above forward PCR primer; 5 0 -CCTCACAGCAGTCTTTCTTTCC-3 0 .
Western blot analysis
Protein lysates from cells were prepared with 1% Triton X-100 in PBS with Halt protease and phosphatase inhibitor cocktail (78440, Thermo Scientific, USA). Protein lysates from GFP-expressing cortical regions of mice embryo (E16) were prepared by homogenizing tissue in lysis buffer (1% Triton X-100, 0.1% SDS, 0.5% Na-deoxycholate, 0.1 M NaCl, 1% NP-40 in 10 mM HEPES). After lysis for 30 minutes at 4 C, they were centrifuged at 13000 rpm for 30 minutes. Supernatants were used for measuring the protein concentration by Pierce BCA assay kit (23225, Thermo, USA). Proteins were resolved by SDS-PAGE and transferred to PVDF membranes (Millipore, USA). The membranes were blocked with 5% BSA (Bovogen, Australia) in TBS containing 0.1% Tween 20 (TBST) for 1 hour at room temperature. They were incubated with diluted primary antibodies including rabbit anti-phosphorylated S6 ribosomal protein (5364, Cell Signaling Technology, USA), rabbit anti-S6 ribosomal protein (2217, Cell Signaling Technology, USA), mouse anti-a tubulin (T6074, Sigma, USA), mouse anti-Flag (8146, Cell Signaling Technology, USA), rabbit anti-OFD1 (gift from Jeremy F. Reiter), rabbit anti-LC3 (NB100-2220, Novus Biologicals, USA), rabbit anti-p62 (PM045, MBL, USA), rabbit anti-Atg5 (NB110-53818, Novus Biologicals, USA) and mouse anti-Myc (2276, Cell Signaling Technology, USA) at 4 C overnight. The next day, the membranes were washed 4 times with TBST for each 10 minutes at room temperature. After washing, they were incubated with diluted secondary antibodies including HRP linked anti-rabbit (7074, Cell Signaling Technology, USA) and HRP linked anti-mouse (7076, Cell Signaling Technology, USA) for 2 hours at room temperature. After washing 4 times with TBST for each 10 minutes at room temperature, immunodetection was performed using ECL reaction reagents.
In utero electroporation and BrdU injection Timed pregnant CD-1 or C57BL/6 mice (E14) were anesthetized with isoflurane (0.4 L/min of oxygen and isoflurane vaporizer gauge 3.5 during surgery operation). Each DNA plasmids were extracted with EndoFree Plasmid Maxi kit (12362, QIAGEN, USA). The uterine horn was exposed, and 1 ml of endotoxin-free plasmids (2 mg/ml) including 0.2% Fast green (F7252, Sigma, USA) per embryo were injected into one side of lateral ventricle using pulled glass capillary. Injected plasmids were electroporated on the head of the embryo by discharging 50 V with the ECM830 electroporator (BTX-Harvard apparatus) in five electric pulses of 100 ms at 900 ms intervals. For cell cycle analysis, BrdU (Bromodeoxyuridine) (100mg/kg) was injected intraperitoneally 2 hours before brain preparation (E16).
Video-Electroencephalography (EEG) monitoring EEG signals from the epidural electrodes located on frontal lobes (AP + 2.8 mm, ML ± 1.5 mm) and temporal lobes (AP -2.4 mm, ML ± 2.4 mm) were recorded using cerebellum as a reference. More than 4 days of recovery from the surgery, EEG signals were recorded for 2$5 ds (6 h/d). Signals were amplified with GRASS model 9 EEG/Polysomnograph (GRASS technologies, USA), recorded with Digidata 1320A (Molecular Devices, USA), and analyzed with pCLAMP program (Molecular Devices, USA).
In vivo rapamycin treatment
Rapamycin was treated as previously described (Lim et al., 2015; Zeng et al., 2008) . In brief, rapamycin (LC Labs, USA) was dissolved initially in 100% ethanol to 20 mg/ml stock solution, stored at À20 C. Immediately before injection, the stock solution was diluted in 5% polyethyleneglycol 400 and 5% Tween 80 to final concentrations of 1 mg/ml rapamycin and 4% ethanol. After observing spontaneous seizures using video recordings and electroencephalography (EEG) recordings, the mice were injected daily through intraperitoneal route with 10 mg/kg rapamycin, or vehicle alone for 2 weeks.
Immunocytochemistry and image analysis Cells were washed with cold PBS, followed by methanol fixation for 5 minutes at À20 C. After washing methanol with PBS, they were blocked with 10% goat serum in PBS for 1 hour at room temperature. They were incubated overnight at 4 C with the following primary antibodies: rabbit anti-Arl13b (17711-1-AP, Proteintech, USA), rabbit anti-p62 (PM045, MBL, USA), mouse anti-acetylated tubulin (T7451, Sigma, USA), rabbit anti-OFD1 (gift from Jeremy F. Reiter), mouse anti-polyglutamylated tubulin (AG-20B-0020, Adipogen, USA), mouse anti-g tubulin (T6557, Sigma, USA), and rabbit anti-Ki67 (ab15580, Abcam, USA). The next day, cells were washed 3 times with PBS for 5 minutes each. After washing, they were incubated 1 hour at room temperature with the following secondary antibodies: Alexa Fluor 555-conjugated goat antibody to mouse (A21422, Thermo Scientific, USA), Alexa Fluor 488-conjugated goat antibody to mouse (A11001, Thermo Scientific, USA), Alexa Fluor 555-conjugated goat antibody to rabbit (A21428, Thermo Scientific, USA), and Alexa Fluor 488-conjugated goat antibody to rabbit (A11008, Thermo Scientific, USA). After incubation, the cells were washed 3 times with PBS for 5 minutes each. The cells were mounted with prolong gold antifade reagent with DAPI (P36931, Thermo Scientific, USA). Images were acquired using a Delta Vision Spectris Imaging System (Applied Precision) and analyzed using ImageJ software (https://imagej.nih.gov/ij).
Immunohistochemistry and image analysis
Brains of E16, E18 mice were harvested and fixed with phosphate-buffered 4% paraformaldehyde at 4 C overnight. The next day, brains were submerged in 30% sucrose for cryoprotection at 4 C until they settle down to bottom. Cryoprotected brains were embedded in gelatin block (7.5% gelatin in 10% sucrose/PB) and stored at À80 C. Brains of adult mice (> P56) were harvested after transcardiac perfusion with phosphate-buffered 4% paraformaldehyde. Then, they were post-fixed with 4% PFA at 4 C overnight. The next day, brains were submerged in 30% sucrose for cryoprotection at 4 C until they settle down to bottom. Cryoprotected brains were embedded in gelatin block (7.5% gelatin in 10% sucrose/PB) and stored at À80 C. For the patient sample, freshly frozen tissues were fixed with phosphate-buffered 4% paraformaldehyde at 4 C overnight. The next day, brains were submerged in 30% sucrose for cryoprotection at 4 C until they settle down to bottom. Cryoprotected brains were embedded in gelatin block (7.5% gelatin in 10% sucrose/PB) and stored at À80 C. Cryostat-cut sections (20 mm thickness) were collected and placed on glass slides. For the cilia staining in patient brain tissues, sections were treated with 1% SDS for 5 min at room temperature before blocking. Sections were blocked with PB-GT (0.2% gelatin, 0.1% Triton X-100 in PBS) for 1 hour at room temperature. They were incubated overnight at 4 C with the following primary antibodies: mouse anti-NeuN (MAB377, Merck Millipore, Germany), rabbit anti-phosphorylated S6 ribosomal protein (5364, Cell Signaling Technology, USA), rabbit anti-CDP (cux1) (sc-13024, Santa Cruz Biotechnology, USA), rabbit anti-Ctip2 (ab28448, Abcam, USA), rabbit anti-Tbr1 (ab31940, Abcam, USA), rabbit anti-AClll (sc-588, Santa Cruz Biotechnology, USA), rabbit anti-p62 (PM045, MBL, USA), rabbit anti-Atg5 (NB110-53818, Novus Biologicals, USA), rabbit anti-Ki67 (ab15580, Abcam, USA), rabbit anti-PH3 (ab5176, Abcam, USA), rat anti-BrdU (ab6326, Abcam, USA), and rabbit anti-Arl13b
